ArticleScientific reports2025
Fatty acid analysis identifies an aberrant circulating triglyceride composition in patients with hypertriglyceridemia-induced acute pancreatitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite a correlative relationship between Hypertriglyceridemia-induced acute pancreatitis (HIAP) incidence and triglyceride (TG) levels, not all patients with very high TG levels in plasma develop HIAP, suggesting additional contributing factors. We used gas chromatography and thin layer chromatography for analysis of fatty acid (FA) composition in plasma, TGs, and red blood cells (RBC) in healthy volunteers and patients with severe hypertriglyceridemia with and without HIAP, providing a thorough understanding of recent and long-standing physiological states. We found that TGs of hypertriglyceridemic patients with current HIAP contain increased levels of oleic acid, linoleic acid, and the trans FA elaidic acid, all potentially toxic to pancreatic cells; and decreased levels of the pancreatic-protective FAs gondoic acid and docosahexaenoic acid. Moreover, we found a significant increase in relative assembly of the pro-inflammatory omega-6 PUFAs into RBC membrane phospholipids in HIAP patients. In conclusion, our data suggest a dietary FA composition characterized by higher consumption of ultra-processed foods and a metabolic milieu that increase HIAP susceptibility, and open avenues for further exploration for development of specific dietary or medical interventions to mitigate HIAP risk by altering the FA composition of plasma TGs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.